{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T19:17:42Z","timestamp":1767640662256,"version":"3.48.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-18-022-010"],"award-info":[{"award-number":["RSG-18-022-010"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-18-022-010"],"award-info":[{"award-number":["RSG-18-022-010"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-18-022-010"],"award-info":[{"award-number":["RSG-18-022-010"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-18-022-010"],"award-info":[{"award-number":["RSG-18-022-010"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-18-022-010"],"award-info":[{"award-number":["RSG-18-022-010"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-18-022-010"],"award-info":[{"award-number":["RSG-18-022-010"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-18-022-010"],"award-info":[{"award-number":["RSG-18-022-010"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-18-022-010"],"award-info":[{"award-number":["RSG-18-022-010"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"DOI":"10.1186\/s12875-025-03076-6","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T08:15:24Z","timestamp":1764404124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The rural adolescent vaccine enterprise (RAVE): a cluster-randomized trial testing a multicomponent intervention to improve HPV vaccination in rural primary care settings"],"prefix":"10.1186","volume":"27","author":[{"given":"Brigit A.","family":"Hatch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steele","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrystal","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nithya","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyle J.","family":"Fagnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Carney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"3076_CR1","unstructured":"Centers for Disease Control and Prevention. Genital HPV Infection \u2014 Fact Sheet. Available from: https:\/\/www.cdc.gov\/std\/hpv\/stdfact-hpv.htm.\u00a0[cited 2020 August 25, 2020]."},{"key":"3076_CR2","unstructured":"Kaiser Family Foundation. The HPV Vaccine: Access and Use in the U.S. Aug, 2024. Available from: https:\/\/www.kff.org\/womens-health-policy\/the-hpv-vaccine-access-and-use-in-the-u-s\/. [cited 2025]."},{"issue":"12","key":"3076_CR3","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S1473-3099(17)30468-1","volume":"17","author":"K Kavanagh","year":"2017","unstructured":"Kavanagh K, et al. Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study. Lancet Infect Dis. 2017;17(12):1293\u2013302.","journal-title":"Lancet Infect Dis"},{"issue":"10197","key":"3076_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","volume":"394","author":"M Drolet","year":"2019","unstructured":"Drolet M, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497\u2013509.","journal-title":"Lancet"},{"issue":"10108","key":"3076_CR5","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/S0140-6736(17)31821-4","volume":"390","author":"WK Huh","year":"2017","unstructured":"Huh WK, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16\u201326 years: a randomised, double-blind trial. Lancet. 2017;390(10108):2143\u201359.","journal-title":"Lancet"},{"issue":"8","key":"3076_CR6","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.4161\/hv.29532","volume":"10","author":"PS Naud","year":"2014","unstructured":"Naud PS, et al. Sustained efficacy, immunogenicity, and safety of the HPV-16\/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination. Hum Vaccin Immunother. 2014;10(8):2147\u201362.","journal-title":"Hum Vaccin Immunother"},{"key":"3076_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100401","volume":"23","author":"SK Kjaer","year":"2020","unstructured":"Kjaer SK, et al. Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four Nordic countries. EClinicalMedicine. 2020;23:100401.","journal-title":"EClinicalMedicine"},{"issue":"12","key":"3076_CR8","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1093\/infdis\/jiaa306","volume":"222","author":"E Meites","year":"2020","unstructured":"Meites E, et al. Vaccine effectiveness against prevalent anal and oral human papillomavirus infection among men who have sex with men-United States, 2016\u20132018. J Infect Dis. 2020;222(12):2052\u201360.","journal-title":"J Infect Dis"},{"issue":"5","key":"3076_CR9","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/infdis\/jix244","volume":"216","author":"SE Oliver","year":"2017","unstructured":"Oliver SE, et al. Prevalence of human papillomavirus among females after vaccine introduction-National health and nutrition examination survey, united states, 2003\u20132014. J Infect Dis. 2017;216(5):594\u2013603.","journal-title":"J Infect Dis"},{"key":"3076_CR10","unstructured":"Office of Disease Prevention and Health Promotion. 2030 Topics and Objectives, Immunization and Infectious Diseases. 2021. Available from: https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/vaccination\/increase-proportion-adolescents-who-get-recommended-doses-hpv-vaccine-iid-08. [cited 2022 January 3]"},{"issue":"6","key":"3076_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.15585\/mmwr.mm7006a1","volume":"70","author":"AP Wodi","year":"2021","unstructured":"Wodi AP, et al. Advisory committee on immunization practices recommended immunization schedule for children and adolescents aged 18 years or younger - United States, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(6):189\u201392.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"35","key":"3076_CR12","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.15585\/mmwr.mm7035a1","volume":"70","author":"C Pingali","year":"2021","unstructured":"Pingali C, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years - United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(35):1183\u201390.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"3076_CR13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jrh.12353","volume":"35","author":"AL Swiecki-Sikora","year":"2019","unstructured":"Swiecki-Sikora AL, Henry KA, Kepka D. HPV vaccination coverage among US teens across the rural-urban continuum. J Rural Health. 2019;35(4):506\u201317.","journal-title":"J Rural Health"},{"key":"3076_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-0361.2009.00204.x","author":"JR Cates","year":"2009","unstructured":"Cates JR, et al. Racial differences in HPV knowledge, HPV vaccine acceptability, and related beliefs among rural, southern women. J Rural Health. 2009. https:\/\/doi.org\/10.1111\/j.1748-0361.2009.00204.x.","journal-title":"J Rural Health"},{"issue":"1","key":"3076_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/heq.2018.0028","volume":"2","author":"D Kepka","year":"2018","unstructured":"Kepka D, et al. Factors associated with human papillomavirus vaccination among diverse adolescents in a region with low human papillomavirus vaccination rates. Health Equity. 2018;2(1):223\u201332.","journal-title":"Health Equity"},{"key":"3076_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ypmed.2018.01.016","volume":"109","author":"KA Mohammed","year":"2018","unstructured":"Mohammed KA, et al. Rural-urban differences in human papillomavirus knowledge and awareness among US adults. Prev Med. 2018;109:39\u201343.","journal-title":"Prev Med"},{"issue":"2","key":"3076_CR17","doi-asserted-by":"publisher","DOI":"10.2196\/cancer.7345","volume":"3","author":"EL Warner","year":"2017","unstructured":"Warner EL, et al. Health care providers\u2019 knowledge of HPV vaccination, barriers, and strategies in a state with low HPV vaccine receipt: mixed-methods study. JMIR Cancer. 2017;3(2):e12.","journal-title":"JMIR Cancer"},{"issue":"3","key":"3076_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.amepre.2020.03.018","volume":"59","author":"R Gunn","year":"2020","unstructured":"Gunn R, et al. Human papillomavirus immunization in rural primary care. Am J Prev Med. 2020;59(3):377\u201385.","journal-title":"Am J Prev Med"},{"issue":"7","key":"3076_CR19","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jamapediatrics.2015.0310","volume":"169","author":"LM Niccolai","year":"2015","unstructured":"Niccolai LM, Hansen CE. Practice- and community-based interventions to increase human papillomavirus vaccine coverage: a systematic review. JAMA Pediatr. 2015;169(7):686\u201392.","journal-title":"JAMA Pediatr"},{"key":"3076_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9070687","author":"EJ Mavundza","year":"2021","unstructured":"Mavundza EJ, et al. A systematic review of interventions to improve HPV vaccination coverage. Vaccines. 2021. https:\/\/doi.org\/10.3390\/vaccines9070687.","journal-title":"Vaccines"},{"key":"3076_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17217997","author":"A Acampora","year":"2020","unstructured":"Acampora A, et al. Increasing HPV vaccination uptake among adolescents: a systematic review. Int J Environ Res Public Health. 2020. https:\/\/doi.org\/10.3390\/ijerph17217997.","journal-title":"Int J Environ Res Public Health"},{"key":"3076_CR22","first-page":"30","volume-title":"A stepped-wedge cluster randomized trial designed to improve completion of HPV vaccine series and reduce missed opportunities to vaccinate in rural primary care practices","author":"PA Carney","year":"2019","unstructured":"Carney PA, et al. A stepped-wedge cluster randomized trial designed to improve completion of HPV vaccine series and reduce missed opportunities to vaccinate in rural primary care practices. Volume 14. Implementation science: IS; 2019. pp. 30\u201330. 1."},{"issue":"6","key":"3076_CR23","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s11606-021-06610-1","volume":"36","author":"MM Davis","year":"2021","unstructured":"Davis MM, et al. Integration of improvement and implementation science in practice-based research networks: a longitudinal, comparative case study. J Gen Intern Med. 2021;36(6):1503\u201313.","journal-title":"J Gen Intern Med"},{"key":"3076_CR24","unstructured":"Office of Rural Health. About Rural and Frontier Data. 2024. Available from: https:\/\/www.ohsu.edu\/oregon-office-of-rural-health\/about-rural-and-frontier-data.\u00a0[cited 2024]"},{"issue":"2","key":"3076_CR25","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1377\/hlthaff.2015.1019","volume":"35","author":"B Walsh","year":"2016","unstructured":"Walsh B, Doherty E, O\u2019Neill C. Since the start of the vaccines for children program, uptake has increased, and most disparities have decreased. Health Aff (Millwood). 2016;35(2):356\u201364.","journal-title":"Health Aff (Millwood)"},{"key":"3076_CR26","unstructured":"Centers for Disease Prevention. Vaccines for Children Program (VFC). 2016 . Available from: https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/index.html.\u00a0[cited January, 2022]"},{"issue":"10","key":"3076_CR27","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1001\/jama.299.10.1182","volume":"299","author":"DM Berwick","year":"2008","unstructured":"Berwick DM. The science of improvement. JAMA. 2008;299(10):1182\u20134.","journal-title":"JAMA"},{"key":"3076_CR28","unstructured":"Agency for Healthcare Quality and Research. Practice Facilitation. 2023; Available from: https:\/\/www.ahrq.gov\/evidencenow\/practice-facilitation\/index.html."},{"key":"3076_CR29","unstructured":"Institute for Healthcare Improvement. How to Improve. 2020. Available from: http:\/\/www.ihi.org\/resources\/Pages\/HowtoImprove\/default.aspx.\u00a0[cited 2020 June 23]"},{"key":"3076_CR30","doi-asserted-by":"crossref","unstructured":"Carney P, Barnes EMB, Ramalingam C, Cox N, Ferrara C, Darden LK, Fagnan PM, Marino LJ, Hatch MB. An exploratory study of primary care community-based partnerships to enhance HPV vaccination., in HPV Cancer Center Consortium. Lexington, KY. 2024.","DOI":"10.1177\/21501319241231405"},{"issue":"2","key":"3076_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/003335491513000209","volume":"130","author":"SG Robison","year":"2015","unstructured":"Robison SG. Addressing immunization registry population inflation in adolescent immunization rates. Public Health Rep. 2015;130(2):161\u20136.","journal-title":"Public Health Rep"},{"issue":"39","key":"3076_CR32","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1016\/j.vaccine.2023.08.017","volume":"41","author":"S Bumatay","year":"2023","unstructured":"Bumatay S, et al. A comparison of electronic health records and the Oregon state immunization registry for human papilloma virus vaccine delivery (2005\u20132022). Vaccine. 2023;41(39):5758\u201362.","journal-title":"Vaccine"},{"issue":"11","key":"3076_CR33","first-page":"300","volume":"64","author":"E Petrosky","year":"2015","unstructured":"Petrosky E, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"49","key":"3076_CR34","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.15585\/mmwr.mm6549a5","volume":"65","author":"E Meites","year":"2016","unstructured":"Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination - Updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65(49):1405\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"3076_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2146434","volume":"18","author":"ST O\u2019Leary","year":"2022","unstructured":"O\u2019Leary ST. Why the American academy of pediatrics recommends initiating HPV vaccine at age 9. Hum Vaccin Immunother. 2022;18(6):2146434.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"3076_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-019-1000-1","volume":"20","author":"ML Parchman","year":"2019","unstructured":"Parchman ML, et al. Assessing quality improvement capacity in primary care practices. BMC Fam Pract. 2019;20(1):103.","journal-title":"BMC Fam Pract"},{"issue":"5","key":"3076_CR37","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s10903-015-0225-x","volume":"18","author":"A Aragones","year":"2016","unstructured":"Aragones A, et al. HPV vaccine and Latino immigrant parents: if they offer it, we will get it. J Immigr Minor Health. 2016;18(5):1060\u20135.","journal-title":"J Immigr Minor Health"},{"issue":"5","key":"3076_CR38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.amepre.2010.01.018","volume":"38","author":"SL Pruitt","year":"2010","unstructured":"Pruitt SL, Schootman M. Geographic disparity, area poverty, and human papillomavirus vaccination. Am J Prev Med. 2010;38(5):525\u201333.","journal-title":"Am J Prev Med"},{"issue":"4","key":"3076_CR39","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.vaccine.2009.10.133","volume":"28","author":"A Dempsey","year":"2010","unstructured":"Dempsey A, et al. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine. 2010;28(4):989\u201395.","journal-title":"Vaccine"},{"key":"3076_CR40","unstructured":"US Census Bureau. Oregon Census Data. 2020. Available from: https:\/\/data.census.gov\/profile\/Oregon?g=040XX00US41.\u00a0[cited 2024]"},{"key":"3076_CR41","unstructured":"Oregon H, Authority OH. HPV Vaccination Rates, 13\u201317 year olds. 2018\u20132024. Available from: https:\/\/public.tableau.com\/app\/profile\/oregon.immunization.program\/viz\/OregonAdolescentImmunizations\/D-Landing.\u00a0[cited 2025 June 20]"},{"key":"3076_CR42","doi-asserted-by":"publisher","DOI":"10.1177\/21501319241231405","volume":"15","author":"PA Carney","year":"2024","unstructured":"Carney PA, et al. Primary care and community-based partnerships to enhance HPV vaccine delivery. J Prim Care Community Health. 2024;15:21501319241231405.","journal-title":"J Prim Care Community Health"},{"key":"3076_CR43","doi-asserted-by":"publisher","DOI":"10.1177\/21501327211014093","volume":"12","author":"BA Hatch","year":"2021","unstructured":"Hatch BA, et al. The importance of practice facilitation in primary care when pandemic takes hold: relationships of resilience. J Prim Care Community Health. 2021;12:21501327211014093.","journal-title":"J Prim Care Community Health"},{"issue":"1","key":"3076_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s43058-024-00563-2","volume":"5","author":"SZ Ahmad","year":"2024","unstructured":"Ahmad SZ, et al. An assessment of adaptation and fidelity in the implementation of an audit and feedback-based intervention to improve transition to adult type 1 diabetes care in Ontario, Canada. Implement Sci Commun. 2024;5(1):25.","journal-title":"Implement Sci Commun"},{"issue":"1","key":"3076_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-016-0457-8","volume":"11","author":"D P\u00e9rez","year":"2016","unstructured":"P\u00e9rez D, et al. A modified theoretical framework to assess implementation fidelity of adaptive public health interventions. Implement Sci. 2016;11(1):91.","journal-title":"Implement Sci"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-03076-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-025-03076-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-03076-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:37:28Z","timestamp":1767627448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12875-025-03076-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3076"],"URL":"https:\/\/doi.org\/10.1186\/s12875-025-03076-6","relation":{},"ISSN":["2731-4553"],"issn-type":[{"type":"electronic","value":"2731-4553"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Every human participant (i.e., clinic staff) provided informed consent to participate. Population-level de-identified data (i.e. vaccination registry data) was used to assess population-level outcomes.\u00a0Research was carried out in compliance with the Helsinki Declaration.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No individual identification is included in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}